Kidney cancer in the elderly.
Kidney cancer in the elderly patient is a real challenge for the oncologic urologist. With the aging population, we will face more patients with renal cell carcinoma in senior adults. There is evidence that elderly patients with RCC have more aggressive disease and lower cancer-specific survival. Proper assessment of the general status and comorbidity of the patient is essential for treatment planning. Most patients can be operated on by surgery or by minimally invasive techniques and methods. Elderly patients with metastatic kidney cancer can benefit from systemic therapy; however, they should be closely monitored for serious adverse events.
Kirkali
Ziya
Z
Department of Urology, Dokuz Eylul University School of Medicine, Izmir, Turkey. ziya.kirkali@deu.edu.tr
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000150:complications / Q000401:mortality / Q000556:secondary / Q000628:therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000150:complications / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D008017:Life Expectancy / Q000639:trends; D019060:Minimally Invasive Surgical Procedures; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome; D013520:Urologic Surgical Procedures / Q000009:adverse effects
D000970:Antineoplastic Agents